What is Queens Endoscopy ASC?
Based in Fresh Meadows, NY, Queens Endoscopy ASC operates as a sophisticated ambulatory endoscopy center dedicated to the diagnosis and treatment of complex gastrointestinal conditions. By integrating advanced medical technology, such as Olympus High Definition 180 Scopes, the center maintains a competitive edge in the detection of bowel abnormalities and chronic digestive issues. The facility distinguishes itself through a commitment to health equity, providing high-quality, patient-centered care in a professional environment that prioritizes comfort and clinical precision for a diverse patient demographic.
How much funding has Queens Endoscopy ASC raised?
Queens Endoscopy ASC has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Queens Endoscopy ASC
PPP
Public-Private Partnership
What's next for Queens Endoscopy ASC?
The infusion of capital is expected to catalyze the next phase of the company's development, focusing on the optimization of patient throughput and the potential scaling of its specialized medical services. As the organization transitions through this late-stage funding cycle, management is likely to prioritize the integration of further diagnostic innovations and the strengthening of its operational framework. By maintaining its focus on high-quality outcomes and accessible care, Queens Endoscopy ASC is poised to solidify its reputation as a leader in the ambulatory surgical center market, ensuring long-term sustainability and continued excellence in gastrointestinal health management.
See full Queens Endoscopy ASC company page
